Human Microbiome Clinical Trial
Official title:
The Influence of a Short-term Gluten-free Diet on the Human Gut Microbiome
NCT number | NCT02731976 |
Other study ID # | M12.113965 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2011 |
Est. completion date | May 2014 |
Verified date | April 2024 |
Source | University Medical Center Groningen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Changes in the gut microbiomes of healthy volunteers who followed a gluten-free diet (GFD) for four weeks were studied. Per participant, nine stool samples were collected: one at baseline, four during the GFD period, and four when they returned to their habitual diet. Microbiome profiles were determined using 16S rRNA sequencing and the samples were next processed for taxonomic and imputed functional composition. Additionally, participants kept a 3-day food diary and six gut health-related biomarkers were measured.
Status | Completed |
Enrollment | 21 |
Est. completion date | May 2014 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 16 Years and older |
Eligibility | Inclusion Criteria: - healthy participants aged >=16 Exclusion Criteria: - Known gastrointestinal disorder - Known food intolerance |
Country | Name | City | State |
---|---|---|---|
Netherlands | University Medical Center Groningen | Groningen |
Lead Sponsor | Collaborator |
---|---|
University Medical Center Groningen |
Netherlands,
Baranska A, Tigchelaar E, Smolinska A, Dallinga JW, Moonen EJ, Dekens JA, Wijmenga C, Zhernakova A, van Schooten FJ. Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet. J Breath Res. 2013 Sep;7(3):037104. doi: — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in gut microbiota composition upon gluten-free diet intervention | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal calprotectin | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: IL-1beta | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal human beta defensin 2 | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal chromogranin A | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal short chain fatty acids: propionate | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma citrulline | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal short chain fatty acids: acetate | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal short chain fatty acids: butyrate | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal short chain fatty acids: valerate | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: fecal short chain fatty acids: caproate | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: IL-6 | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: IL-8 | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: IL-10 | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: IL-12 | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet | ||
Secondary | Changes in gut associated biomarker levels: plasma cytokines: TNFalpha | baseline, 4 weeks gluten-free diet and 4 weeks habitual diet |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05560087 -
Association of PeRiODontal Disease and gUt Microbiome With Coronary artEry Disease (PRODUCE Study)
|
||
Completed |
NCT04222699 -
Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization
|
Phase 4 | |
Completed |
NCT02392182 -
Lung HIV Microbiome Project (Michigan Site)
|
N/A | |
Completed |
NCT04597502 -
The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties
|
N/A | |
Completed |
NCT04596722 -
Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties
|
N/A | |
Completed |
NCT05150184 -
Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
|
||
Recruiting |
NCT03942159 -
Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
|
||
Completed |
NCT04335526 -
A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles
|
Phase 1 | |
Completed |
NCT03668015 -
Xylitol and Sorbitol Effects on the Oral Microbiome
|
N/A | |
Completed |
NCT03157687 -
Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation
|
||
Not yet recruiting |
NCT04841694 -
Oral Probiotics on the Shift in Gut Microbiome and Skin Carotenoid Levels
|
N/A | |
Enrolling by invitation |
NCT03231332 -
Effects of H.Pylori Eradication on Microbiome
|
Phase 4 | |
Completed |
NCT03181269 -
Human Milk and Infant Intestinal Microbiome Study
|
N/A | |
Completed |
NCT03543605 -
Clinical/Microbiological Impact of a Specific Antimicrobial Stewardship Program for Nursing Homes
|
N/A | |
Completed |
NCT01496898 -
Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement
|
N/A | |
Terminated |
NCT03907501 -
Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation
|
N/A | |
Completed |
NCT03809260 -
A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin
|
N/A | |
Completed |
NCT04218799 -
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
|
Phase 4 | |
Completed |
NCT03581812 -
Snack Foods and Their Impact on Gastrointestinal Microbiology, Function and Symptoms
|
N/A | |
Withdrawn |
NCT02407184 -
Potential Restoration of the Infant Microbiome
|
N/A |